Alcon lifts 2026 outlook after Q2 adjusted EPS beat estimates

Alcon AG

10/08/2026 21:41

Overview
Global eye care leader's Q2 sales rose 8%, slightly beating analyst expectations
Adjusted EPS for Q2 beat consensus, driven by new product launches and commercial execution
Company returned $538 mln to shareholders year-to-date via dividends and share repurchases

Outlook
Alcon maintains 2026 net sales growth guidance at +5% to +7% constant currency
Company raises 2026 core operating margin guidance to +90 to +190 bps vs prior year
Alcon increases 2026 core diluted EPS growth guidance to +12% to +15% constant currency

Result Drivers
NEW PRODUCT LAUNCHES - Co said recent launches such as UNITY, PanOptix Pro, and TRYPTYR drove growth across the portfolio
EQUIPMENT SALES - Equipment/other net sales rose 26%, led by recent equipment launches including the Unity platform
OCULAR HEALTH PRODUCTS - Growth in ocular health was led by dry eye products, including TRYPTYR and Systane

Company press release: ID:nBw2cDHrQa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Slight Beat*
$2.78 bln
$2.77 bln (13 Analysts)
Q2 Adjusted EPS
Beat
$0.84
$0.75 (13 Analysts)
Q2 EPS
 
$0
 
Q2 Core Operating Margin
 
20.6%
 
Q2 Operating Margin
 
0.4%
 
*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 1 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Alcon AG is CHF80.00, about 37.2% above its August 10 closing price of CHF58.32
The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 21 three months ago

Reuters Recommended Reads
Aug 10 - Switzerland's MoonLake Q2 net loss narrows as expenses fall
Aug 10 - Harrow Q2 revenue slightly beats estimates
Aug 10 - Eli Lilly's weight-loss pill secures first European nod in Britain

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)